Azelaic acid 15 % gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies;15 % Azelainsäuregel in der behandlung der akne. Zwei doppelblinde klinische vergleichsstudien

JDDG - Journal of the German Society of Dermatology

Volumn 2, Issue 10, 2004, Pages 841-847

  Gollnick, Harald P M ^a,c   Graupe, Klaus ^b   Zaumseil, Rolf Peter ^b  

^a Univ Hautklinik Magdeburg   (Germany)

^b BAYER PHARMA AG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Azelaic acid; Benzoylperoxide; Clindamycin; Papulo pustular acne; Randomized clinical trials; Topical treatment

Indexed keywords

AZELAIC ACID; BASOCIN; BENZOYL PEROXIDE; CLINDAMYCIN; SCHEROGEL; UNCLASSIFIED DRUG;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYDROGEL; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAPULE; PHASE 3 CLINICAL TRIAL; PUSTULE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SKIN IRRITATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; CHILD; CLINDAMYCIN; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DOUBLE-BLIND METHOD; FEMALE; GELS; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 6044248939     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2004.04731.x     Document Type: Article

References (20)

1. Bergfeld W. The evaluation and management of acne: economic considerations. J Am Acad Dermatol 1995; 32: S52-56.
2. Gollnick H, Krautheim A. Topical treatment in acne: current status and future aspects. Dermatology 2003; 206: 29-36.
3. Gollnick H, Cunliffe W. Management of acne. A report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003; 49: S1-38.
4. Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa T. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases. Arch Dermatol Res 1991; 283: 162-166.
5. Gloor M, Koehler S, Fluhr J. Benzoyl-peroxid. in: Korting HC, Sterry W. Therapeutische Verfahren in der Dermatologie. Berlin: Blackwell, 2001: 265-272.
6. Akhavan A, Bershad S. Topical acne drugs. Review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003; 4: 473-492.
7. Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, Swinehart JM, Schelling DJ, Klauda HC. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 1997; 37: 590-595.
8. Leyden JJ, Hickman JG, Jarrat MT, Stewart DM, Levy SF. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001; 5: 37-42.
9. Leyden JJ, McGinley KJ, Cavalieri S, Webster GF, Mills OH, Kligman AM. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41-45.
10. Eady EA, Jones CE, Tipper JL, Cove JH, Cunliffe WJ, Layton AM. Antibiotic-resistant propionibacteria in acne: need for policies to modify antibiotic usage. Br Med J 1993; 306: 555-556.
11. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Perez Del Pulgar JI, Rollman O, Torok L, Eady EA, Cove JH. Antibiotic-resistant acne. Lessons from Europe. Br J Dermatol 2003; 148: 467-478.
12. Eady EA, Bojar RA, Jones CE, Cove JH, Holland KT, Cunliffe WJ. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996; 134: 107-113.
13. Graupe K, Zaumseil RP. Skinoren - ein neues Lokaltherapeutikum zur Behandlung der Acne vulgaris. In: Macher E, Kolde G, Bröcker EB. Jahrbuch der Dermatologie 1991/92, Zülpích: Biermann, 1992: 159-169.
14. Gollnick, H, Graupe K. Azelaic acid for the treatment of acne: comparative trials. J Dermatol Treatm 1989; 1: 276-230.
15. Graupe K, Cunliffe W, Gollnick H, Zaumseil RP. Efficacy and safety of topical azelaic acid (20 percent cream) an overview of results from European clinical trials and experimental reports. Cutis 1996; 57: 20-35.
16. Gollnick H. Azelainsäure. In: Korting HC, Sterry W. Therapeutische Verfahren in der Dermatologie. Berlin: Blackwell, 2001: 253-264.
17. Mayer-da Silva A, Gollnick H, Imcke E, Orfanos CE. Azelaic acid vs. placebo: effects on normal human keratinocytes an melanocytes. Acta Dermato Venereol (Stockh) 1987; 67: 116-122.
18. Detmar M, Mayer-da Silva A, Stadler A, Orfanos CE. Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J Invest Dermatol 1989; 93: 70-74.
19. Barbareschi M, Hendricks I, Angius A, Cattaneo M, Monti M. The anticome-dogenic activity of azelaic acid investigatied by means of scanning electron microscopy on horny layer biopsy. J Dermatol Treatm 1991; 2: 55-57.
20. Gollnick H, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocyclin with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538-544.